Intestinal Helminthiasis
📧 Sign up to get email alerts when something new happens for Intestinal Helminthiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms [Phase 2, Phase 3]
A Phase 2/3 trial comparing albendazole-ivermectin coformulation to albendazole for intestinal helminth infections has been terminated. Resu…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Immune Modulation From Trichuris Suis
A completed clinical trial evaluated Trichuris suis ova as an immune-modulating therapy for Crohn's disease and ulcerative colitis. Intestin…
-
CLINICAL_TRIALS withdrawal · 2016-12-15Clinical Trial Update: The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School Children [Phase 4]
Phase 4 clinical trial evaluating anthelmintic treatment to reduce diarrheal disease incidence in Vietnamese schoolchildren was withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Immune Modulation From Trichuris Trichiura
A completed clinical trial investigating immune modulation by exposure to Trichuris trichiura in Crohn's disease, ulcerative colitis, and in…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children [NA]
A completed clinical trial assessing whether repeated anthelmintic treatment influences the risk of malaria in Kenyan schoolchildren.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Impact of Health Education on School Children [Phase 1]
Phase 1 trial evaluated a health education intervention targeting intestinal helminthiasis in school children; the study has completed.
-
CLINICAL_TRIALS research · 2012-03-05Clinical Trial Update: A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes [NA]
This Clinical Trial Update examines co-infections of HIV-1 and Schistosoma mansoni and how they influence praziquantel treatment outcomes.